Search Tag: prostate cancer
2024 05 Apr
A groundbreaking study presented at the Society of Interventional Radiology Annual Scientific Meeting unveils the potential of a minimally invasive treatment for prostate cancer using MRI-guided transurethral ultrasound ablation (TULSA). This innovative approach offers an effective alternative to traditional treatments like surgery or radiation,...Read more
2023 22 Aug
According to a new study, a 10-minute MRI scan could be used to screen men for prostate cancer. The scans demonstrated significantly higher accuracy in diagnosing cancer compared to blood tests that rely on finding high levels of a protein known as PSA. MRI technology successfully identified several serious cancers that would have gone undetected...Read more
2023 03 May
A three-year Pan-European project, known as the PRAISE-U project, aims to reduce morbidity and mortality caused by prostate cancer through smart early detection. Prostate cancer is the leading and second leading cause of cancer death among men in northern and western Europe. Every year, an estimated 450,000 European men are diagnosed with prostate...Read more
2022 01 Mar
Innovative rhPSMA Theranostic technology has the potential to offer both diagnostic imaging and treatment for patients affected by prostate cancer. Blue Earth Therapeutics has exclusive worldwide rights to therapeutic applications of radiohybrid Prostate-Specific Membrane Antigen (rhPSMA) radiopharmaceutical technology. “ We are increasingly...Read more
2021 25 Jan
Prostate cancer is one of the most common cancers among men. Patients are determined to have prostate cancer based on Prostate-Specific Antigen (PSA), a prostate-specific antigen used as an index for the screening of prostate cancer. However, diagnostic accuracy for prostate cancer is as low as 30%. That is why a large number of patients have to undergo...Read more
2019 02 Dec
Good news for men with prostate problems including prostate cancer and benign prostate enlargement. A new minimally invasive method, the MRI-guided transurethral ultrasound ablation (TULSA), has been shown to be effective in treating prostate cancer with minimal side effects, according to a new study presented at the annual meeting...Read more
2018 04 Jul
A large number of radiotracers are currently being evaluated for prostate-specific membrane antigen (PSMA) PET, which is becoming a central tool in the staging of prostate cancer, according to a review published in the American Journal of Roentgenology. Staging in various clinical contexts of prostate cancer, such as the preoperative setting...Read more
2018 12 Jun
In a single-centre cohort study of 1,020 men who underwent both biparametric targeted and standard transrectal ultrasound-guided biopsies, low-suspicion biparametric magnetic resonance imaging (bpMRI) had a high negative predictive value (97%) in ruling out significant prostate cancer on confirmatory biopsies. The findings are published online...Read more
2018 05 Jun
The new RAPID (Rapid Assessment Prostate Imaging and Diagnosis) programme accelerates the pathway which could lead to a ‘one-stop shop’ for men with prostate cancer by providing a multi-parametric MRI together with ultrasound imaging and biopsy on the same day. This will reduce unnecessary biopsies and provide accurate targeting whilst reducing the...Read more
2018 17 Apr
New research from Thomas Jefferson University suggests that contrast-enhanced subharmonic imaging (SHI) could be useful in detecting prostate cancers that are not identified by MRI. The findings will be presented at the ARRS 2018 Annual Meeting, set for 22-27 April in Washington, DC. SHI is a new technique for imaging of microbubble ultrasound contrast...Read more
2018 14 Feb
German researchers have found a new marker for differentiating cancerous tissue from healthy tissue in prostate cancer patients. Based on their study, the maximum standardised uptake value (SUVmax) on Gallium-68 prostate specific membrane antigen (68Ga-PSMA) PET/CT scans correlates with PSMA-expression in primary prostate cancer. With this method,...Read more
2017 09 Oct
A new report from medical imaging IT and cybersecurity company Sectra shows in what areas of the diagnostic process radiologists themselves see the added value of machine learning. The report clearly shows more opportunities than threats. Artificial Intelligence (AI) and machine learning are set to disrupt the practice of radiology. How and...Read more
2017 20 Jun
According to new research presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), prostate-specific molecular imaging could improve clinical management, especially in patients whose cancer returns. The study includes data from four Australian medical centres and several hundred patients who were examined...Read more
2017 23 May
Magnetic resonance (MR) imaging–guided strategies for the detection of prostate cancer were cost-effective compared with the standard biopsy strategy, according to a new study published in the journal Radiology. The current standard for detecting prostate cancer is a systematic transrectal ultrasonography (US)-guided biopsy with the acquisition of...Read more
2017 04 Apr
Despite evidence and guidelines for appropriate imaging use in patients with low-risk prostate cancer, studies have shown only gradual reductions in inappropriate imaging use, according to an article published in Journal of the American College of Radiology. See Also : MRI Improves Prostate Cancer Detection, Avoids Unneeded Biopsy Waste contributes...Read more
2017 24 Jan
An MRI scan given to men with suspected prostate cancer can help reduce rates of unnecessary biopsy by 27 percent and overdiagnosis by 5 percent, says a new study appearing in The Lancet. See Also : Novel MRI Method Distinguishes Healthy Prostate Tissue from Cancer It's common for men to undergo a biopsy of their prostate if they experience...Read more
2016 23 Aug
Radiologists from UT Southwestern Medical Center have used a novel MRI technique that detects low levels of zinc ion and can help distinguish healthy prostate tissue from cancer. The findings are published in the Proceedings of the National Academy of Sciences . MRIs in general are unable to distinguish between zinc levels in healthy, malignant,...Read more
2016 18 Jul
Photoacoustic imaging (PAI) may be an effective tool for more accurately viewing and monitoring prostate cancer, according to findings by a team of researchers led by scientists from Roswell Park Cancer Institute in Buffalo, New York. The challenge for clinicians has been to monitor and distinguish early-stage tumors from advanced cases,...Read more
2016 15 Jun
Researchers in the United States are conducting tests using an image-guided biopsy robot (biobot) system to diagnose and support treatment of prostate cancer, just as about a thousand patients in Asia and Europe have already benefited from the tool that offers precise localisation. The University of Alabama at Birmingham is one of two beta...Read more
2016 02 Jun
Physicians have long used MRI to detect cancer, but results of a study in California describe the potential use of RSI as an imaging biomarker that enhances the ability to differentiate aggressive prostate cancer from low-grade or benign tumours and guide treatment and biopsy. "Noninvasive imaging is used to detect disease, but RSI-MRI takes...Read more
2016 31 Mar
A bigger radiation dose will not improve the long-term chances of patients with non-metastatic prostate cancer, a new study in the U.S. by Thomas Jefferson University has found. Despite advances in technology that has allowed doctors to administer higher radiation doses to prostate cancer patients with fewer side effects, the new study, published...Read more
2016 22 Jan
Researchers in the U.S. have found that nearly 16 percent of individuals 65 years or older may have received non-recommended screenings for breast and prostate cancers because they had limited life expectancies of less than 10 years. The finding, reported in JAMA Oncology , could help inform measures to curb unnecessary and potentially harmful cancer...Read more
2016 11 Jan
Amidst growing appreciation of the harms of cancer screening, advocates still claim that it “saves lives". However, this assertion is based on reductions in disease specific mortality rather than overall mortality, according to a BMJ article published by Vinay Prasad, MD, MPH, Assistant Professor at Oregon Health and Science University, and colleagues....Read more
2015 17 Dec
Using PET/CT with whole-body MRI (WBMRI) is effective in detecting extraskeletal disease, according to Stanford University researchers who suggest that this technique may change the management of high-risk breast and prostate cancer patients. The researchers also found that the combined administration of F-18 sodium fluoride (NaF) and F-18 fluorodeoxyglucose...Read more
2015 25 Aug
A Johns Hopkins-led study shows that PET imaging with a specific biomarker could detect fast-growing primary prostate cancer and distinguish it from benign prostate lesions. The finding, reported in The Journal of Nuclear Medicine , is important for patients with suspected prostate cancer that has not been confirmed by standard biopsy. The study...Read more